Those reports suggest that induction of CD8+ cytotoxic T cells at the tumor site by re-polarizing TAMs to produce M1-related chemokines could enhance the anti-tumor immune response to anti-PD1 Abs. This evidence concerns the gene CD8A and neoplasm.